{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:02:05Z","timestamp":1740106925880,"version":"3.37.3"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T00:00:00Z","timestamp":1656115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00277-022-04898-5","type":"journal-article","created":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T14:04:53Z","timestamp":1656165893000},"page":"2351-2352","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Forodesine maintenance therapy for newly diagnosed peripheral T-cell lymphoma: a single-institutional, observational, retrospective analysis"],"prefix":"10.1007","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3471-0890","authenticated-orcid":false,"given":"Masaki","family":"Iino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayato","family":"Nakadate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoya","family":"Onuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyuki","family":"Takayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,25]]},"reference":[{"issue":"3","key":"4898_CR1","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00277-016-2891-8","volume":"96","author":"H Kitahara","year":"2017","unstructured":"Kitahara H, Maruyama D, Maeshima AM et al (2017) Prognosis of patients with peripheral T cell lymphoma who achieve complete response after CHOP\/CHOP-like chemotherapy without autologous stem cell transplantation as an initial treatment. Ann Hematol 96(3):411\u2013420","journal-title":"Ann Hematol"},{"issue":"25","key":"4898_CR2","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes international T-cell lymphoma project. J Clin Oncol 26(25):4124\u20134130","journal-title":"J Clin Oncol"},{"issue":"7","key":"4898_CR3","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1111\/j.1349-7006.2012.02287.x","volume":"103","author":"M Ogura","year":"2012","unstructured":"Ogura M, Tsukasaki K, Nagai H et al (2012) Phase I study of BCX1777 (forodesine) in patients with relapsed or refractory peripheral T\/natural killer-cell malignancies. Cancer Sci 103(7):1290\u20131295","journal-title":"Cancer Sci"},{"issue":"1","key":"4898_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00277-018-3418-2","volume":"98","author":"D Maruyama","year":"2019","unstructured":"Maruyama D, Tsukasaki K, Uchida T et al (2019) Multicenter phase 1\/2 study of forodesine in patients with relapsed peripheral T cell lymphoma. Ann Hematol 98(1):131\u2013142","journal-title":"Ann Hematol"},{"issue":"14","key":"4898_CR5","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"International non-Hodgkin\u2019s lymphoma prognostic factors project","year":"1993","unstructured":"International non-Hodgkin\u2019s lymphoma prognostic factors project (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 329(14):987\u2013994","journal-title":"N Engl J Med"},{"issue":"7","key":"4898_CR6","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","volume":"103","author":"A Gallamini","year":"2004","unstructured":"Gallamini A, Stelitano C, Calvi R et al (2004) Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study. Blood 103(7):2474\u20132479","journal-title":"Blood"},{"issue":"2","key":"4898_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M et al (2013) Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol 31(2):240\u2013246","journal-title":"J Clin Oncol"},{"key":"4898_CR8","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.2147\/OTT.S140756","volume":"11","author":"S Makita","year":"2018","unstructured":"Makita S, Maeshima AM, Maruyama D, Izutsu K, Tobinai K (2018) Forodesine in the treatment of relapsed\/refractory peripheral T-cell lymphoma: an evidence-based review. Onco Targets Ther 11:2287\u20132293","journal-title":"Onco Targets Ther"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-022-04898-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-022-04898-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T06:05:37Z","timestamp":1662703537000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-022-04898-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,25]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["4898"],"URL":"https:\/\/doi.org\/10.1007\/s00277-022-04898-5","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2022,6,25]]},"assertion":[{"value":"28 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of Yamanashi Prefectural Central Hospital and was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}